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Abstract
Background: High blood pressure in patients with stroke increases the risk of recurrence but
management in the community is often inadequate. Home blood pressure monitoring may increase
patients' involvement in their care, increase compliance, and reduce the need for patients to attend
their General Practitioner if blood pressure is adequately controlled. However the value of home
monitoring to improve blood pressure control is unclear. In particular its use has not been
evaluated in stroke patients in whom neurological and cognitive ability may present unique
challenges.
Design: Community based randomised trial with follow up after 12 months.
Participants: 360 patients admitted to three South London Stroke units with stroke or transient
ischaemic attack within the past 9 months will be recruited from the wards or outpatients and
randomly allocated into two groups. All patients will be visited by the specialist nurse at home at
baseline when she will measure their blood pressure and administer a questionnaire. These
procedures will be repeated at 12 months follow up by another researcher blind as to whether the
patient is in intervention or control group.
Intervention: Intervention patients will be given a validated home blood pressure monitor and
support from the specialist nurse. Control patients will continue with usual care (blood pressure
monitoring by their practice).
Main outcome measures in both groups after 12 months:
1. Change in systolic blood pressure.
2. Cost effectiveness: Incremental cost of the intervention to the National Health Service and
incremental cost per quality adjusted life year gained.
Trial registration: Clinical Trials.gov registration NCT00514800
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Background
Poorly controlled blood pressure (BP) in people with
stroke or transient ischaemic attack (TIA) increases the
risk of recurrence but is difficult to manage in the commu-
nity. Our recent meta-analysis provides some evidence
that home monitoring of BP is associated with better BP
control [1]. If true, this could be important for stroke pre-
vention. However there was considerable heterogeneity
between trials and the current value of self monitoring
remains uncertain [2,3]. Many studies showing reductions
in BP were underpowered, had inadequate length of fol-
low up or were done many years ago [1,4]. Reduction of
antihypertensive treatment based on home BP instead of
clinic BP may lead to less intensive drug treatment and
worse control [5], and there is an urgent need for an eco-
nomic evaluation of home BP monitoring [6]. No trials
have been conducted in people with stroke [4].
Home BP monitoring could benefit people with stroke
both by improving BP control thus reducing the risk of
recurrent stroke, and by enabling them to be more
involved in treatment decisions [2,7]. It has been shown
to improve compliance with treatment and to remove
white coat syndrome [5]. McManus et al recently found
practice based self monitoring was well received by
patients with no apparent increase in anxiety or cost [4].
However attending a general practice may be difficult or
inconvenient for many people with stroke. Home BP
monitoring can reduce the number of visits to the surgery
[8]. But in people with stroke it may present particular
challenges due to the neurological and cognitive disability
which may affect both ability to successfully use the
equipment and compliance.
Following our meta-analysis of home monitoring [1], we
have just completed a community based study of nurse
led BP management [9]. As in our proposed trial, this
study included 25% of patients of African origin who are
known to be at increased risk of stroke [10,11]. In addi-
tion our ongoing experience in GP outreach hypertension
clinics suggests that the use of home BP monitoring is
increasing and is feasible in patients with stroke or TIA.
Self monitoring should include regular professional
supervision and check of the patient's measuring tech-
nique [2], clear treatment goals adjusted for lower home
readings, and a willingness to intensify drug treatment
[3,6]. Combined with nurse led support, the introduction
of home BP monitoring is a realistic and pragmatic inter-
vention for patients in general practice which is where
most BP management takes place. Before home BP moni-
toring becomes widespread in the UK, there is an oppor-
tunity for a robust trial to see if it is a feasible, effective and
cost effective option for stroke patients living in the com-
munity [3].
Questions to be answered
a. Does home monitoring of BP and patient held BP tar-
gets with support from a specialist nurse lower systolic BP
after 12 months compared with usual care?
b. Is home blood pressure monitoring cost effective?
c. What is the effect of home BP monitoring on quality of
life, anxiety, number of prescribed anti hypertensive drugs
and number of medication changes?
d. How does disability affect the success of home monitor-
ing in people with stroke?
Methods/Design
Recruitment
Patients will be recruited from three South London stroke
units: St George's, St Helier and Mayday hospitals.
Identification of patients
The research nurse will ask one of the stroke doctors or
nurses which patients on the stroke/TIA ward or stroke/
TIA clinic might be suitable to be approached about the
study. Information sheets about the trial and a card with
inclusion/exclusion criteria will be available on the wards
and in the clinics.
Inclusion criteria
• Patient has had a stroke or TIA within the last 9 months.
￿ Patient is hypertensive defined as on antihypertensive
treatment for raised BP, or BP>140/85 mmHg when meas-
ured more than a week after a stroke/TIA.
Exclusion criteria
￿ Severe illness or another major illness likely to dominate
the pattern of care eg advanced cancer.
￿ Already using a home BP monitor.
￿ Non-English speaking.
￿ Severe cognitive impairment defined as Abbreviated
Mental Test Score (AMTS) <7.
￿ Known secondary hypertension.
Consent procedure
The research nurse will introduce herself and ask the
patient (and carer if present) if they would consider help-
ing in a research study of home BP monitoring in people
with stroke or TIA. If they are interested she will give them
an information sheet to read, show them a BP monitor,
briefly explain the study and answer any questions.Trials 2008, 9:15 http://www.trialsjournal.com/content/9/1/15
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If the patient is willing to take part, she will give them a
consent form to sign.
For patients who wish to discuss the study with their GP
or other people first, she will give them a consent form
and stamped addressed envelope to complete and post
back if they wish to participate.
Information to be obtained at the time of consent
Date of birth, gender, contact details and details of GP,
date of most recent stroke or TIA.
In addition the research nurse will classify the degree of
stroke related disability using the modified Rankin score
and confirm that participants are hypertensive (on antihy-
pertensive therapy or BP>140/85 mmHg). These data will
be entered on the preliminary data collection sheet. Age,
sex and Rankin score will be used in the randomisation
procedure. The nurse will carry out an AMTS assessment
to check eligibility for the study.
Medical record search
Patients signing the consent form agree for the researchers
to have access to their hospital and GP medical records.
When possible, clinical details, including imaging and
stroke sub-typing and risk factors profile will be extracted
from the hospital records and/or the local hospital stroke
register where available, and entered on the trial data col-
lection sheet.
Randomisation
Patients who consent will be stratified by age, sex and
Rankin score and randomly allocated into two groups by
the principal investigator (Sally Kerry) using a computer
programme. The allocation for each patient will be put in
a sealed envelope which will be opened by the specialist
nurse after completion of the baseline assessment at
home.
Information for the patient's GP (all patients)
The research team will write to the patient's GP informing
them of the patient's participation in the study explaining
that the BP target for home monitoring (<130/80 mm Hg)
is lower than that for clinic readings. As with hospital let-
ters, we will request that the letter is scanned into the
patient's computerised GP medical records and filed in
their paper notes. In addition the GP will be sent a lami-
nated A4 copy of the NICE/BHS ACD 2006 Hypertension
Guidelines [7], and a brief outline of the study's aims and
design. The letter will be sent just prior to the baseline
home visit. We anticipate patients will come from about
100 different GP practices.
Baseline assessment at home
The research nurse will telephone the patient to arrange a
convenient time to visit. The visit will be done within 2
months of discharge from the ward or recruitment in the
clinic. She will answer the patient's questions, confirm
they are still willing to participate and carry out the base-
line assessment.
Baseline clinical measurements
BP and pulse rate will be measured with an automatic
machine (Omron 705 CP sphygmomanometer with
printout) after the participant has been sitting upright for
at least 5 minutes. The appropriate cuff size will be used
(13 by 32, or 16 by 42 cm if arm circumference is ≥ 33
cm). Three readings will be taken 1 minute apart. The first
will be discarded and the mean of the last two used in the
analysis.
If BP is consistently over 170/105 mm Hg, including
when repeated at the end of the home visit, and the
patient is relaxed and has been taking their medication
regularly, she will advise them to see their GP in the next
3 days. (If BP is consistently above 210/115 mmHg, she
will advise them to see the GP immediately). If tablets
have been missed she will emphasise the importance of
taking medication regularly to prevent another stroke/
TIA, and ask them to see their GP in the next two weeks.
Height will be measured when possible without shoes
using a height rule to the nearest 0.5 cm.
Weight will be measured to the nearest 0.5 kg with man-
ual Seca 761 scales.
These will be entered on the data collection sheet.
Structured Questionnaire
The nurse will administer a questionnaire. This will
include:
1. Self-assigned ethnicity.
2. Lifestyle: smoking, alcohol, exercise, dietary salt, and
fruit and vegetable intake.
3. Medical history: previous stroke or TIA, diabetes, atrial
fibrillation, cardiovascular disease.
4. Current drug treatment and knowledge of target BP.
5. Validated instruments: Quality of life (EQ-5D) [12],
Level of anxiety (FEAR 4 item scale) [13].Trials 2008, 9:15 http://www.trialsjournal.com/content/9/1/15
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Treatment allocation
After completing the baseline assessment the nurse will
open the sealed envelope to see if the patient is in the
intervention or control group.
Control group
These patients will continue with usual care -BP monitor-
ing by their practice. The research nurse will telephone
them at 1, 6 and 9 months and encourage healthy diet and
exercise.
Intervention group
Patients in the intervention group will receive all of the
following:
Home BP monitor
The nurse will give the patient (and/or carer) a validated
BP monitor Omron M6 with appropriate size cuff and
teach the patient or carer how to take their BP using a
standardised method and taking 3 readings each time
[14]. She will give them a specially prepared booklet
"Blood Pressure Record Booklet". This explains the
method of BP measurement, target BP and actions to be
taken if BP is above target, and also has tables in which to
record BP. The nurse will advise the participant to meas-
ure their BP every morning and evening under standard-
ised conditions for a week (omitting the first 24 hours
readings) and then weekly on the same day each week and
record readings in the booklet.
Target BP
The nurse will explain that home BP target is <130/80 mm
Hg [7] (less if diabetic) and that their GP may not know
this as this is less than clinic targets. A sticker with target BP
and the nurse's telephone number will be put on the BP
monitor. Instructions on the record card will advise the
patient what to do if readings taken on 3 different occa-
sions are consistently raised. First telephone the specialist
nurse for advice in case they are taking their BP wrongly or
the machine is faulty. If appropriate, the nurse may visit
them again within a week to check this. Otherwise for BP
consistently 131/81–169/104 mmHg make a routine
appointment with GP. For BP 170/105–209/114 see GP
within 3 days. For BP over 210/115 mmHg see GP or
attend A+E immediately.
Telephone support from specialist nurse
The nurse will encourage patients to ring her mobile in
working hours if they have any queries. This is particularly
important in the first week of using the home BP monitor.
If she is unavailable they should leave a message so she
can ring them back.
Follow up home visit after a month and continued telephone support
After a month the nurse will revisit to check that patients
are taking their BP correctly and record any problems
patients are having with either using the equipment or
understanding the results. For those with BP consistently
above target she will advise the patient to see their GP tak-
ing their BP booklet with them. The booklet gives the GP
a record of the home BP readings with the target home BP
of <130/80 mmHg clearly shown. She will also give them
a note to give the GP suggesting s/he considers changing
antihypertensive treatment, and a copy of the 2006 joint
NICE/BHS ACD guidelines [7]. Following this second visit
she will provide telephone support 2 weekly and a further
visit if appropriate until target BP is reached, with further
telephone calls at 6 and 9 months.
Assessment of outcome after 6 and 12 months in 
intervention and control groups
6 month assessment at home
An independent researcher unaware of whether the
patient is in the intervention or control group will assess
the patient at home. She will explain that she should not
know which group the patient is in so at both assessment
visits the patient should put away their BP monitor if they
have one and avoid telling her whether or not they are
monitoring their BP. At this assessment s/he will just
record BP (using the Omron 705CP automatic sphyg-
momanometer with printout) according to the standard-
ised method set out previously.
Final 12 month assessment at home
At 12 months s/he will measure BP (according to the
standardised method) and weight before administering
the final questionnaire. This should reduce any effect of
possible unblinding. As at baseline, the questionnaire will
include:
1. Lifestyle: smoking, alcohol, exercise, dietary salt, and
fruit and vegetable intake.
2. Medical history in the past year: previous stroke or TIA,
diabetes, atrial fibrillation, cardiovascular disease.
3. Current drug treatment and knowledge of target BP.
4. Validated instruments: Quality of life (EQ-5D) [11],
Level of anxiety (FEAR 4 item scale) [13].
To capture any impact of the intervention on other areas
of the health service [15], the questionnaire will also ask
about health service use. We will ask how many times in
the last 12 months the participant has: a) seen their GP b)
seen a practice/community nurse c) had an outpatient
appointment d) had a hospital stay. For at least 10% of
patients we will cross-validate their questionnaire data onTrials 2008, 9:15 http://www.trialsjournal.com/content/9/1/15
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usage of the health service in the past year using practice
records.
Outcome measures
Primary outcome
Change in systolic BP after 12 months.
Secondary outcomes
Change in systolic BP after 6 months; change in diastolic
BP after 6 and 12 months, number of prescribed antihy-
pertensive drugs; number of changes in prescribed antihy-
pertensive drugs; change from baseline in scores for EQ-
5D, FEAR questionnaire, and knowledge of target BP.
Cost effectiveness
Incremental cost of the intervention to the NHS [15] and
incremental cost per quality adjusted life year gained
(QALY). To be consistent with other studies we will follow
the methods of the reference case as advocated by the
NICE [16]. To calculate QALYs, life expectancy will be esti-
mated on the basis of the measured risk factors; and
improvements in quality of life will be estimated using the
EQ-5D at baseline and twelve months [17,18]. We expect
the main cost of the intervention to the health service will
be the nurse time. The research nurse will complete a
timesheet distinguishing between time spent on the inter-
vention from time spent on research elements of the
project. Resource use will be costed using standard NHS
sources [19-21].
Statistical analysis and sample size
The primary analysis will compare change in systolic
blood pressure over the year between the intervention and
control groups using a t test. Secondary analysis will com-
pare secondary outcomes in intervention and control
groups but also investigate effect of disability and cogni-
tion on change in systolic blood pressure and nurse's
record of difficulties with home monitoring in the inter-
vention group. Characteristics of patients recruited will be
compared with those on the Stroke Register not taking
part to assess the generalisability of the results to stroke
patients. A sample size of 322 will be able to detect a dif-
ference of 5 mmHg [1] in change at 12 months between
the intervention and control group with 80% power using
a 5% significance level assuming the SD is 16 mmHg [9].
Allowing for a 10% loss to follow up [12] we will need to
recruit 360 patients.
Conclusion
If home blood pressure monitoring is shown to be feasi-
ble, effective and cost effective, encouraging people with
stroke to use home BP monitoring could improve BP con-
trol and reduce risk of recurrence. It will also assist GPs
and practice nurses in the management of blood pressure
in patients with stroke.
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